Bioporto A/S
CSE:BIOPOR

Watchlist Manager
Bioporto A/S Logo
Bioporto A/S
CSE:BIOPOR
Watchlist
Price: 1.466 DKK 2.23%
Market Cap: 629.9m DKK

Relative Value

The Relative Value of one BIOPOR stock under the Base Case scenario is 1.299 DKK. Compared to the current market price of 1.466 DKK, Bioporto A/S is Overvalued by 11%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BIOPOR Relative Value
Base Case
1.299 DKK
Overvaluation 11%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
71
vs Industry
27
Median 3Y
19.5
Median 5Y
21.1
Industry
7.3
Forward
15.6
vs History
vs Industry
Median 3Y
-10.2
Median 5Y
-10.3
Industry
21.6
Forward
-8.1
vs History
vs Industry
Median 3Y
-9.9
Median 5Y
-10
Industry
19.8
vs History
vs Industry
Median 3Y
-9.3
Median 5Y
-9.3
Industry
24.9
vs History
80
vs Industry
3
Median 3Y
8.5
Median 5Y
10.6
Industry
2.4
vs History
74
vs Industry
24
Median 3Y
17.2
Median 5Y
20
Industry
7.4
Forward
13.8
vs History
80
vs Industry
15
Median 3Y
26.9
Median 5Y
30.2
Industry
9.3
vs History
vs Industry
Median 3Y
-8.6
Median 5Y
-8.9
Industry
3.9
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-8.6
Industry
3.7
Forward
-6.9
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9.1
Industry
4.9
vs History
vs Industry
Median 3Y
-9
Median 5Y
-9.1
Industry
3.2
vs History
68
vs Industry
6
Median 3Y
22.4
Median 5Y
22.4
Industry
4.3

Multiples Across Competitors

BIOPOR Competitors Multiples
Bioporto A/S Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
Bioporto A/S
CSE:BIOPOR
629.9m DKK 18 -10.3 -8.3 -8.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 36 460 420.5 -173 291 -210 430.4 -208 029.2
US
Abbvie Inc
NYSE:ABBV
373.8B USD 6.6 88.2 17.2 26
US
Amgen Inc
NASDAQ:AMGN
168.4B USD 5 41.2 16.6 29.3
US
Gilead Sciences Inc
NASDAQ:GILD
138.9B USD 4.8 289.3 11.3 14.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
129.7B USD 11.8 -242.2 26.5 27.8
US
Epizyme Inc
F:EPE
94.1B EUR 1 932.2 -493 -536.9 -522.6
AU
CSL Ltd
ASX:CSL
119.6B AUD 5 27.5 17 21.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
73.1B USD 5.1 16.6 10.9 12.2
US
Seagen Inc
F:SGT
39.3B EUR 18.6 -57.1 -61.4 -55.4
NL
argenx SE
XBRU:ARGX
32.9B EUR 16.4 43 317.6 -2 339.9
P/S Multiple
Revenue Growth P/S to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average P/S: 3 314 767.6
18
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
36 460 420.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.6
8%
0.8
US
Amgen Inc
NASDAQ:AMGN
5
4%
1.3
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
11.8
10%
1.2
US
E
Epizyme Inc
F:EPE
1 932.2
N/A N/A
AU
CSL Ltd
ASX:CSL
5
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.1
7%
0.7
US
S
Seagen Inc
F:SGT
18.6
30%
0.6
NL
argenx SE
XBRU:ARGX
16.4
37%
0.4
P/E Multiple
Earnings Growth PEG
DK
Bioporto A/S
CSE:BIOPOR
Average P/E: 84.3
Negative Multiple: -10.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -173 291 N/A N/A
US
Abbvie Inc
NYSE:ABBV
88.2
88%
1
US
Amgen Inc
NASDAQ:AMGN
41.2
44%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
289.3
185%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -242.2 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -493 N/A N/A
AU
CSL Ltd
ASX:CSL
27.5
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.6
11%
1.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.1 N/A N/A
NL
argenx SE
XBRU:ARGX
43
19%
2.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average EV/EBITDA: 59.6
Negative Multiple: -8.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -210 430.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
17.2
13%
1.3
US
Amgen Inc
NASDAQ:AMGN
16.6
14%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
11.3
6%
1.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.5
16%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -536.9 N/A N/A
AU
CSL Ltd
ASX:CSL
17
12%
1.4
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.9
17%
0.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.4 N/A N/A
NL
argenx SE
XBRU:ARGX
317.6
168%
1.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
Bioporto A/S
CSE:BIOPOR
Average EV/EBIT: 21.8
Negative Multiple: -8.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -208 029.2 N/A N/A
US
Abbvie Inc
NYSE:ABBV
26
29%
0.9
US
Amgen Inc
NASDAQ:AMGN
29.3
31%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
14.2
10%
1.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.8
15%
1.9
US
E
Epizyme Inc
F:EPE
Negative Multiple: -522.6 N/A N/A
AU
CSL Ltd
ASX:CSL
21.3
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.2
17%
0.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -2 339.9 N/A N/A